Actividentity Corporation (ACTI) > Press Releases

Active Biotech: Laquinimod Phase IIb Trial confirms efficacy and favorable safety profile and shows significant reduction in the rate of inflammatory disease activity

Tue, 5 Sep 2006 8:02:00 PDT

LUND, SWEDEN -- (MARKET WIRE) -- 09/05/2006 -- The once-daily novel oral agent for relapsing remitting multiple sclerosis (MS) patients met its primary endpoint

Contact

Topics

Pharmaceuticals and Biotech
Chemicals

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.